• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccination

tetano

Editor, Senior Moderator
Proteomics. 2017 May 15. doi: 10.1002/pmic.201600453. [Epub ahead of print]
[h=1]Proteomics show antigen presentation processes in human immune cells after AS03-H5N1 vaccination.[/h] Galassie AC[SUP]1[/SUP], Goll JB[SUP]2[/SUP], Samir P[SUP]3[/SUP], Jensen TL[SUP]2[/SUP], Hoek KL[SUP]4[/SUP], Howard LM[SUP]5[/SUP], Allos TM[SUP]4[/SUP], Niu X[SUP]4[/SUP], Gordy LE[SUP]4[/SUP], Creech CB[SUP]5[/SUP], Hill H[SUP]2[/SUP], Joyce S[SUP]4,[/SUP][SUP]6[/SUP], Edwards KM[SUP]5[/SUP], Link AJ[SUP]1,[/SUP][SUP]3,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Adjuvants enhance immunity elicited by vaccines through mechanisms that are poorly understood. Using a systems biology approach, we investigated temporal protein expression changes in five primary human immune cell populations: neutrophils, monocytes, natural killer (NK) cells, T-cells, and B-cells after administration of either an Adjuvant System 03 (AS03)-adjuvanted or unadjuvanted split-virus H5N1 influenza vaccine. Monocytes demonstrated the strongest differential signal between vaccine groups. On day 3 post-vaccination, several antigen presentation-related pathways, including MHC class I-mediated antigen processing and presentation, were enriched in monocytes and neutrophils and expression of HLA Class I proteins was increased in the AS03 group. We identified several protein families whose proteomic responses predicted seroprotective antibody responses (>1:40 Hemagglutination inhibition titer), including inflammation and oxidative stress proteins at day 1 as well as immunoproteasome subunit (PSME1 and PSME2) and HLA Class I proteins at day 3 in monocytes. While comparison between temporal proteomic and transcriptomic results showed little overlap overall, enrichment of the MHC Class I antigen processing and presentation pathway in monocytes and neutrophils was confirmed by both approaches. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] AS03; Avian influenza; Immune response; Quantitative proteomics; Vaccine

PMID: 28508465 DOI: 10.1002/pmic.201600453
 
Back
Top Bottom